- For the first time, a new MSKCC study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.
- IBM announced that Dr. Spriggs of MSKCC will join its Watson Healthcare Advisory Board. The advisory board will specifically focus on medical industry trends, clinical imperatives, regulatory considerations, privacy concerns and patient and clinician expectations around Watson technology and how it can be incorporated into clinician workflows.
Category Archives: In the News
Blog Buzz: February 27 – March 2
In a carefully worded statement released Monday, Elsevier withdrew support for HR3699, also known as the Research Works Act. Later that same day representatives sponsoring the bill in the House announced they were dropping it too, and open access advocates cheered across the social media universe! Michael Eisen congratulated everyone and reminded readers that there are more battles for open access to come. Here is the NY Times’ take on the issue of access to publicly funded research, and Jen Howard of the Chronicle for Higher Education on the end of the RWA.
Michelle Kraft posted a nice rundown of which social media sites own your content and how in The Devil is in the Details: Social Media’s Right to Your Content.
A Washington Post piece called The world’s most boring journal–and why it’s good for Science has been making a splash on Twitter.
The FDA has added new warnings to statins and may fine Merck for failure to conduct postmarketing tests of two diabetes drugs.
And, last but not least, the NY Times on the unveiling of Microsoft’s Windows 8.
Cancer Research News: February 15 – February 28
- FDA approves axitinib for advanced kidney cancer.
- Soy Isoflavone supplements did not decrease breast cancer proliferation in an RCT.
- A new journal, Cancer & Metabolism, is now accepting submissions.
- U.S. imports doxil and methotrexate to ease cancer drug shortage.
- High platelet levels are associated with poor survival in ovarian cancer patients.